Calcimedica, Inc.
Clinical trials sponsored by Calcimedica, Inc., explained in plain language.
-
New injection tested to calm dangerous pancreatitis inflammation
Disease control CompletedThis study tested an investigational injection called CM4620-IE in adults hospitalized with acute pancreatitis and a dangerous whole-body inflammatory response (SIRS). The main goal was to check the safety of the drug and see how well it worked when added to standard hospital car…
Phase: PHASE2 • Sponsor: CalciMedica, Inc. • Aim: Disease control
Last updated Apr 02, 2026 07:26 UTC
-
New drug aims to speed recovery from painful pancreatic attacks
Disease control CompletedThis study tested whether a new drug called Auxora could help people hospitalized with a severe form of acute pancreatitis. Researchers gave 216 patients either Auxora or a placebo (inactive substance) for three days to see if it helped them tolerate solid food sooner and reduced…
Phase: PHASE2 • Sponsor: CalciMedica, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Drug trial aims to speed recovery from severe COVID lung damage
Disease control CompletedThis study tested if a new drug called Auxora could help hospitalized adults with severe COVID-19 pneumonia. In the main part of the trial, 284 patients were randomly assigned to receive either Auxora or a placebo (inactive substance) infusion over three days, along with standard…
Phase: PHASE2 • Sponsor: CalciMedica, Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC